Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 16 of 16

TitleReference numberPublishedLast updated
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)TA730
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)TA731
Lateral elbow resurfacing for arthritisIPG705
Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesisIPG706
Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repairIPG707
Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA726
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA727
Midostaurin for treating advanced systemic mastocytosisTA728
Sapropterin for treating hyperphenylalaninaemia in phenylketonuriaTA729
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyTA725
OrganOx metra for liver transplantMIB275
Carnation Ambulatory Monitor for ambulatory detection of cardiac arrythmiasMIB276
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancerTA724
Workplace health: long-term sickness absence and capability to workQS202
End of life care for adultsQS13
Bimekizumab for treating moderate to severe plaque psoriasisTA723

Results per page

  1. 10
  2. 25
  3. 50
  4. All